Patents by Inventor Jenny Roy

Jenny Roy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of 17?-HSD1, 17?-HSD3 and 17?-HSD10
    Patent number: 11072632
    Abstract: The present application discloses 17? hydroxy steroid dehydrogenase (17? HSD) type 1, 3, 10 inhibitors and use thereof (alone and in combination) in the treatment of cancer and other afflictions. 17? HSD1 inhibitors include estradiol derivatives with a nieta-carbamoylbenzyl substituent at C 16. 17? HSD3/HSD10 inhibitors include androsterone derivatives substituted at the C3 position with a sulfonamide piperazine. Also disclosed are compounds that are inhibitors of both 17? HSD1 and 17? HSD3 that have a spiro-morpholine substituent at C20.
    Type: Grant
    Filed: March 26, 2012
    Date of Patent: July 27, 2021
    Assignee: UNIVERSITÉ LAVAL
    Inventors: Donald Poirier, Jenny Roy, Rene Maltais
  • INHIBITORS OF 17Beta-HSD1, 17Beta-HSD3 AND 17Beta-HSD10
    Publication number: 20140088053
    Abstract: The present application discloses 17? hydroxy steroid dehydrogenase (17? HSD) type 1, 3, 10 inhibitors and use thereof (alone and in combination) in the treatment of cancer and other afflictions. 17? HSD1 inhibitors include estradiol derivatives with a nieta-carbamoylbenzyl substituent at C 16. 17? HSD3/HSD10 inhibitors include androsterone derivatives substituted at the C3 position with a sulfonamide piperazine. Also disclosed are compounds that are inhibitors of both 17? HSD1 and 17? HSD3 that have a spiro-morpholine substituent at C20.
    Type: Application
    Filed: March 26, 2012
    Publication date: March 27, 2014
    Applicant: UNIVERSITÉ LAVAL
    Inventors: Donald Poirier, René Maltais, Jenny Roy
  • 2-(N-substituted piperazinyl) steroid derivatives
    Patent number: 8653054
    Abstract: Novel chemical agents are described herein. More specifically, 2-(N-substituted piperazinyl) pregnane and 2-(N-substituted piperazinyl) androstane derivatives exhibiting cytotoxicity on a variety of cancer cell lines are disclosed herein.
    Type: Grant
    Filed: November 25, 2009
    Date of Patent: February 18, 2014
    Assignee: Universite Laval
    Inventors: Donald Poirier, Jenny Roy, Rene Maltais
  • 2-(N-Substituted Piperazinyl) Steroid Derivatives
    Publication number: 20110312926
    Abstract: Novel chemical agents are described herein. More specifically, 2-(N-substituted piperazinyl) pregnane and 2-(N-substituted piperazinyl) androstane derivatives exhibiting cytotoxicity on a variety of cancer cell lines are disclosed herein.
    Type: Application
    Filed: November 25, 2009
    Publication date: December 22, 2011
    Applicant: UNIVERSITE LAVAL
    Inventors: Donald Poirier, Jenny Roy, Rene Maltais